drugset
drugset / Trial / NCT07297940

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

NCT07297940 ↗

Phase 1 Completed 42 enrolled Dong-A ST Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fasting state.

Timeline

Start
2025-12-14
Primary completion
2026-01-31
Completion
2026-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-1229_01 Unknown — —
Subject DA-1229_01-R Unknown — —

Indications

No indication recorded.